Ian Sanne
University of the Witwatersrand
South Africa
About
No AI summary yet.
Metrics
- Publications
- 311
- Citations
- 17.8K
- h-index
- 58
- Publishing journals
- 93
- Years of publications
- 20+
- Active since
- 2007
- References
- 7.3K
- Institutions
- 28
Publication history
Latest publications
- Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial
- Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data
- Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in Myanmar
- Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: A cohort study among HIV-infected adults initiating HAART in South Africa
- Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
- Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa
- Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)
- Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household
- High Asymptomatic Carriage With the Omicron Variant in South Africa
- Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts
- Persistent Symptoms among Frontline Health Workers Post-Acute COVID-19 Infection
- Safety evaluation of the single-dose Ad26. COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
- Trends In Cases, Hospitalisation And Mortality Related To The Omicron Ba.4/Ba.5 Sub-Variants In South Africa
- Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients
- Voluntary medical male circumcision in selected provinces in South Africa: Outcomes from a programmatic setting
- Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set
- Allergic reactions to the Ad26.COV2.S vaccine in South Africa
- Recovery and transforming the South African health system
- Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics
- Caregiver willingness to give TPT to children living with drug-resistant TB patients
No publications in the index yet.